SYRS
Syros Pharmaceuticals Inc.

2,959
Loading...
Loading...
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Syros Pharmaceuticals Inc.?
What is the 52-week high for Syros Pharmaceuticals Inc.?
What is the 52-week low for Syros Pharmaceuticals Inc.?
What is Syros Pharmaceuticals Inc. stock price today?
What was Syros Pharmaceuticals Inc. stock price yesterday?
What is the PE ratio of Syros Pharmaceuticals Inc.?
What is the Price-to-Book ratio of Syros Pharmaceuticals Inc.?
What is the 50-day moving average of Syros Pharmaceuticals Inc.?

Latest SYRS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.